Therapeutics Exam 4 (Inflammatory Bowel Disease) Flashcards

1
Q

What 2 disease states make up Irritable Bowel Disease (IBD)?

A

Ulcerative Colitis

Crohn’s Disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What parts of the body are affected by Ulcerative Colitis (UC)?

A

Rectum and Colon

-mucosal + submucosal inflammation (more superficial)
-only affects the lower GI tract

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What parts of the body are affected by Crohn’s Disease (CD)?

A

Any part of the GI tract from the mouth to the anus

-Transmural inflammation of any part of the GI tract
-Terminal ileum is most common
-CD normally affects tissue deeper than UC

*Rectal involvement is uncommon
*Perianal disease is common

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What physical appearance specific to Crohn’s disease can help differentiate it from other conditions?

A

Crohn’s disease appears as discontinuous segments of infected bowel with normal bowel separating it

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What effect does smoking have on ulcerative colitis?

A

Potentially protective

-reduced disease activity, fewer flare-ups

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What effect does smoking have on Crohn’s disease?

A

Increases severity

-increased disease frequency and severity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

**What is the main drug class that can trigger IBD?

A

NSAIDs!!!!

patients need to avoid these
-may trigger disease occurrence or lead to flares

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Which drug class has a potential association with triggering IBD?

A

Antibiotics

*causal relationship is unclear

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the 2 main symptoms of ulcerative colitis?

A

Diarrhea + Bleeding

-due to mucosal damage and friability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What life-threatening complications are we concerned about with UC?

A

Toxic Megacolon

Colonic dysplasia/Colorectal cancer (CRC)

note that fistulas and strictures are UNCOMMON

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the defining features of toxic megacolon?

A

Severe and potentially fatal complication of UC

-Segmental or total colonic distention (>6cm)
-Acute colitis
-Signs of systemic toxicity

*50% mortality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What complications are we concerned about with Crohn’s disease?

A

Small bowel stricture

Obstruction

Fistula formation is common

Less bleeding is seen than with UC but anemia is still possible

Carcinoma, but not as likely as with UC

Nutritional deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is a fistula?

A

A connection between 2 areas that should not be connected in the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which laboratory test for UC correlates with the degree of inflammation present?

A

Fecal Calprotectin (FC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How is UC diagnosed?

A

-Clinical suspicion

-Confirmed by endoscopy (colonoscopy or sigmoidoscopy) and biopsy

-Negative stool examination for infectious causes (Cdiff)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is hematochezia?

A

Blood in stool

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

True or False: IBD can be cured

A

False, no medications are curative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are the drug classes used in IBD treatment?

A

ASAs (aminosalicylates)
Corticosteroids
Immunomodulators (suppressives)
Biologics
Antimicrobials

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What drugs are considered aminosalicylates (ASA)?

A

Sulfasalazine
Mesalamine (5-ASA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What drugs are considered immunomodulators (immunosuppressives)?

A

Azathioprine
Mercaptopurine (MP)
Cyclosporine
Methotrexate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the two categories of biologics?

A

Anti-TNF-a

Other

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are the Anti-TNF-a drugs?

A

Infliximab
Adalimumab
Certolizumab
Golimumab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are the other biologic drugs?

A

Natalizumab
Vedolizumab
Ustekinumab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What are the antimicrobial drugs?

A

Metronidazole
Ciprofloxacin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What are the 2 components of sulfasalazine?

A

Sulfapyridine + Mesalamine (5-ASA)

-5-ASA is the active compound
-Sulfapyridine is associated with ADR’s!

26
Q

If sulfapyridine causes ADR’s then why do we not just give mesalamine alone?

A

We can!

-But it is very rapidly absorbed in the small intestine and giving it alone prevents it from staying in the lumen where it is needed
-But we can use local forms like: enemas, suppositories, or delayed release forms

27
Q

What area is involved in proctitis UC?

A

Rectal area

28
Q

What area is involved in pancolitis UC?

A

Majority of colon

29
Q

Which drug form works best for proctitis?

A

Suppository

30
Q

Which drug form works best for left-sided disease?

A

Enema

31
Q

Which drug form works best for extensive disease + pancolitis?

A

Systemic tx

32
Q

What is therapeutic drug monitoring used for?

A

To determine drug and anti-drug antibody concentrations

33
Q

What drugs have the most data for therapeutic drug monitoring?

A

Infliximab
Adalimumab

34
Q

When should we consider doing therapeutic drug monitoring?

A

If there is a loss of treatment response

-This monitoring is done reactively, we do not check it to see how the patient is doing

35
Q

If a patient undergoes Therapeutic Drug Monitoring and has Detectable Antibodies + Sub-Therapeutic Drug Levels, what do we do?

A

Change to alternate drug in the SAME class +/- immunomodulator

-This is an immune mediated pharmacokinetic failure
-We can still keep the patient on the same drug class especially if they had a good initial response to the original drug

36
Q

If a patient undergoes Therapeutic Drug Monitoring and has Detectable Antibodies + Therapeutic Drug Levels, what do we do?

A

Repeat the levels to check for false positive

Switch to a biologic from a different drug class

37
Q

If a patient undergoes Therapeutic Drug Monitoring and has No Antibodies with Sub-Therapeutic Drug Levels what do we do?

A

Escalate the dose

38
Q

If a patient undergoes Therapeutic Drug Monitoring and has No Antibodies with Therapeutic Drug Levels but no response what do we do?

A

Switch to a biologic from another class

-The patient is just not responding to the drug for an unknown reason
-If they do not respond to one, they probably will not respond to another in the same class

39
Q

For mild-moderate active UC, if the patient has extensive disease what do we use as first-line therapy?

A

Oral 5-ASA

Sulfasalazine
Mesalamine

40
Q

For mild-moderate active UV, if the patient has left sided disease what do we use as first-line therapy?

A

5-ASA enema

-topical mesalamine enema

41
Q

For mild-moderate active UV, if the patient has proctitis what do we use as first-line therapy?

A

5-ASA suppository

-mesalamine suppository

42
Q

When may a combination of oral and topical options for UC be more effective?

A

Pts with left-sided/extensive disease

43
Q

Which monotherapy works better: topical or oral?

A

Topical typically

44
Q

If a patient is unresponsive to 5-ASA, what is the next step?

A

Consider changing the dosage form

45
Q

If a patient is unresponsive to standard-dose 5-ASA or continues having moderate disease activity, what is the next step?

A

High dose mesalamine (>3g/day) + Rectal Mesalamine

(combo therapy)

46
Q

If a patient with mild-moderate UC is refractory to ASA’s what is the next step?

A

PO corticosteroids

-Budesonide
-Prednisone

47
Q

Budesonide usage should be limited to what?

A

<8-16 weeks

48
Q

When are topical corticosteroids an option? (foams, enemas, suppository)

A

Distal disease
(ex: left sided, proctitis)

49
Q

For moderate UC, besides mesalamine, what is the other potential first line option?

A

PO Controlled Release Budesonide

50
Q

True or False: 5-ASA therapy is the first-line option for severe UC

A

No, it is probably not going to be effective

51
Q

What is the first-line therapy for Severe UC?

A

Systemic corticosteroids

(po prednisone)

-consider TNF-a inhibitors/biologics

52
Q

True or False: we should continue 5-ASA therapy in moderate-severe UC patients who achieve remission with biologics/immunosuppressants

A

FALSE
-do not continue 5-ASA as induction or maintenance in these pts

53
Q

What are the first-line options for severe UC treatment?

A

Option 1:
-Budesonide or Prednisone

Option 2 (Treatment Naive):
-Prednisone + Infliximab or Vedolizumab +/- Azathioprine

Option 3 (Previous infliximab exposure):
Ustekinumab to Tofacitinib

54
Q

What are the first-line treatment options for severe-fulminant UC?

A

Parenteral Corticosteroids
-methylprednisolone
-hydrocortisone
(IV then po)

Consider TNF-a Inhibitors
-infliximab

Consider cyclosporine or infliximab in pts unresponsive to IV steroids

55
Q

What drugs should be used for maintenance of remission for UC?

A

ASA

TNF-a antagonist (infliximab/adalimumab)

Patients who are steroid dependent:
-Azathioprine
-6-MP

-make choice based on what patient has already been started on

56
Q

Which drug class should not be used to maintain remission in UC?

A

Corticosteroids

57
Q

What is the first-line therapy for mild-moderate CD?

A

Sulfasalazine

-mesalamine has no efficacy
-these drugs do not work super well

58
Q

What is the first-line therapy for moderate-severe CD?

A

Systemic corticosteroids
(po prednisone)
-may be more effective than budesonide

If hospitalized:
-IV corticosteroids
(methylprednisolone, hydrocortisone)

Early biologic therapy may be useful
(TNF-a inhibitors)
(combo therapy of infliximab or adalimumab + AZA may be more effective)

59
Q

What treatment options should we use for severe/fulminant CD?

A

Parenteral corticosteroids (if no abscess)
-methylprednisolone
-hydrocortisone

Consider infliximab or other biologic if not already attempted

60
Q

What drug may be preferred for fulminant CD?

A

Infliximab

-last option before surgery

61
Q

What drugs can we use for maintenance of remission with CD?

A

AZA and 6-MP

Methotrexate

TNF-a Antagonists

Vedolizumab, Ustekinumab, Risankizumab